- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01226433
Family Planning Through Dairy Cooperatives
Providing Family Planning Services Sustainably Through Dairy Cooperatives in Kenya
Studieöversikt
Status
Detaljerad beskrivning
Access to family planning and other reproductive health services remains difficult in much of rural Kenya. One option for improving rural access to family planning is to use existing community events outside of the health sector as platforms for delivering information and services. This study will assess a model for providing family planning through quarterly events organized by dairy cooperatives supported by Land O'Lakes in Kenya. During these events, known as Field Days, a healthcare provider will have a tent in which Field Day attendees can receive basic family health services free of charge. The services offered will be: family planning counseling and methods, immunizations, antenatal care, screening and treatment for sexually transmitted infections, and HIV counseling and testing. Since the services are no different than those that could be obtained at Ministry of Health or some private facilities, the service provision is not considered to be part of the research.
Women receiving any service from the health care provider will be recruited for an interview that will measure their demand for family planning and attitudes about receiving services during the field day. In addition, the study will track the number of different types of services provided, the total number of Field Day attendees, and the cost of the service model. The study will be carried out at five Field Days in Rift Valley and Central provinces.
Participants will not be tested for STI/HIV as part of this research; however, at their request, they may have received a test from the provider prior to the research interview. At the time of consent, they will have already received the test, so the consent form will not include anything specific to testing. In Kenya, all STI/HIV test results are reported to the national public health authorities. These reports are not used for contacting patients but for planning purposes.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
Rift Valley & Central
-
Various, Rift Valley & Central, Kenya
- 5 Community Outreach Events
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:females aged 18-49 receiving health services at a field day event -
Exclusion Criteria:
-
Studieplan
Hur är studien utformad?
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Health Services Research
Tidsram: 1 year
|
Unmet need for family planning among women attending Field Days aged 18-49
|
1 year
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Health Services Research
Tidsram: 1 year
|
Interest in receiving health services through Field Day model
|
1 year
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: John Bratt, MPP, MA, FHI 360
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
- AE biverkning
- AIDS förvärvat immunbristsyndrom
- ALT (SGPT) alaninaminotransferas
- ART antiretroviral terapi
- AST (SGOT) aspartataminotransferas
- DCF datainsamlingsformulär
- DMC Dataövervakningskommitté
- FDA (U.S.) Food and Drug Administration
- GCP:s riktlinjer för god klinisk praxis
- HB sAg Hepatit B ytantigen
- ICH International Conference of Harmonization
- IND Investigational New Drug Application
- IRB institutionell granskningsnämnd
- IU internationella enheter
- mg milligram(er)
- mm3 kubikmillimeter(ar)
- PCR-polymeraskedjereaktion
- SAE allvarlig biverkning
- µg mikrogram
- ULN övre gräns för normalområdet
- WB Western Blot
Andra studie-ID-nummer
- 10227
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .